Letermovir Intravenous and Tafenoquine (Prevention of Malaria Relapse)
Determining the interaction of Letermovir Intravenous and Tafenoquine (Prevention of Malaria Relapse) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: letermovir
Brand name: Prevymis
Synonyms: Letermovir (oral/injection), Letermovir
Generic Name: tafenoquine
Brand name: Arakoda, Krintafel
Synonyms: Tafenoquine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Letermovir Intravenous-Tafenoquine Succinate (Arakoda)
- Letermovir Intravenous-Tafenoquine Succinate (Krintafel)
- Letermovir Intravenous-Tafinlar
- Letermovir Intravenous-Tafluprost
- Letermovir Intravenous-Tafluprost ophthalmic
- Letermovir Intravenous-Tagamet
- Tafenoquine (Prevention of Malaria Relapse)-Letermovir oral/injection
- Tafenoquine (Prevention of Malaria Relapse)-Letermovir Tablets
- Tafenoquine (Prevention of Malaria Relapse)-Letrozole
- Tafenoquine (Prevention of Malaria Relapse)-Letrozole and ribociclib
- Tafenoquine (Prevention of Malaria Relapse)-Leucovorin
- Tafenoquine (Prevention of Malaria Relapse)-Leucovorin Calcium